Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
4568.T - Daiichi Sankyo Co Ltd
Daiichi Sankyo Co Ltd Science and Technology Day
Dec 15, 2025 / 10:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative, [1]
--------------------------------------------------------------------------------
DXT ADC, the business, we will further expand the business under such circumstances, those new initiatives that have been, rolled out. Please understand that that's all from me.
Thank you very much. The second question is also the question directly to Adesan. As you mentioned earlier on page 25, new ADC 12 3, for these, the target, for instance, HER2 or 2, like that, the conventional DXT ADC.
It's the same as that, but A further, stronger efficacy, safety, targeted ones are included, or the past DXD ADC, the new target that you were not able to obtain, and for those new patients, it's a kind of effort for you to provide a treatment option, which is closer to what you are aiming at as a
Trustpilot
